GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
about
Galanin pathogenic mutations in temporal lobe epilepsyPositive allosteric modulators to peptide GPCRs: a promising class of drugsEfficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms.Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealed.Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2.Synthesis and biological evaluation of novel pyrimidine derivatives as sub-micromolar affinity ligands of GalR2.Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.Galanin receptors and ligands.Anticonvulsant neuropeptides as drug leads for neurological diseases.The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation.Ghrelin: an emerging new anticonvulsant neuropeptide.Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.Galanin receptors as a potential target for neurological disease.Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinomaReceptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala.Galanin modulates human and murine neutrophil activation in vitro.
P2860
Q24319705-56A8E84B-9F4E-404E-AC98-258BF3A3281AQ27002663-64CFA1A3-D82C-49FC-8E4C-C95DE847BA3DQ30560643-5F2E7902-3F84-4CFD-B421-B86B56195805Q33659932-2651EEBB-D99F-4527-97F3-85FBAFF6E8F7Q35132304-23DB36F7-8C12-4317-9A97-85C527E2E48AQ35753039-47E20F8A-86D5-4EDF-803A-BDF5E1EC2EDFQ35972120-C7701A69-3FA5-467D-92D6-D5BBBA812E39Q36451712-06015797-F767-4BF4-8712-687353F65B1AQ37845684-B8E61762-2AF9-430A-AFD9-8213B26274B6Q37871070-FC3D2C4F-DF66-4FA8-BFBE-8D7432664812Q37993592-22B2E3B5-891E-4DD1-99AB-E22335CF9B7DQ38060667-41A54DC6-672C-4519-A8D6-4710F62D97D5Q38556483-FCDAA46E-74F5-4B49-828D-D005C9458F1EQ39587210-14F8018F-7E7E-45BD-B6A3-3C966CC55A10Q40198165-F0BD74B9-8A7F-47FB-B399-AE3F6D1735F6Q46793121-D0D1AE5E-D10D-469D-A0C3-9BD618738A0A
P2860
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@ast
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@en
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@nl
type
label
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@ast
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@en
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@nl
prefLabel
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@ast
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@en
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@nl
P2093
P2860
P356
P1476
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
@en
P2093
Claude G Wasterlain
Edward Roberts
Fengcheng Xia
James Chang
Roger Baldwin
Stephanie Wu
Tianyu Liu
Xiaoying Lu
P2860
P304
15229-15234
P356
10.1073/PNAS.1008986107
P407
P577
2010-07-26T00:00:00Z